Figure 1 — Human mesenchymal stem cells treatment improved hepatic lesions and reversed gut microbiome disorder in non-alcoholic steatohepatitis

Research Paper|Volume 12, Issue 21|pp. 21660–21673

Human mesenchymal stem cells treatment improved hepatic lesions and reversed gut microbiome disorder in non-alcoholic steatohepatitis

Back to articleFigure 1(1 of 5)

100%

Figure 1.Human umbilical cord mesenchymal stem cells were successfully isolated. (A) Isotype antibodies were used as the control group of hMSCs. (B) Immunophenotypic features of hMSCs include being positive for CD90, CD105, and CD73 and negative for CD34, CD45, CD11b, CD19, and HLA-DR.